Hemab Therapeutics
PublicHemab Therapeutics is now publicly traded
The data on this page reflects Hemab Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
May 1, 2026
Last Round
Series C
Oct 27, 2025
Total Funding Raised
$853.66M
Company Overview
Hemab Therapeutics is a biotechnology company that develops prophylactic therapeutics aimed at treating bleeding and thrombosis disorders by enhancing the body's natural clotting mechanisms to prevent life-threatening complications.
Sector
Biotech
Verticals
Digital Health, HealthTech, Life Sciences
AI Layer
Non-AI
Keywords
Hemab Therapeutics Comparables
Compare Hemab Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 77% | |
| Incyte Corporation | 76% | |
| Novo Nordisk | 72% |
Hemab Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | May 1, 2026 | ||||
| Series C | Oct 27, 2025 | ||||
| Series C | Oct 27, 2023 | ||||
| Series B | Feb 16, 2023 | ||||
| Series A | Jul 22, 2021 | ||||
Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Access Industries | Series B |
| Evercore ISI | IPO |
| Maj Invest Equity A/S | Series B, Series C |
| RA Capital Management | Series C, Series B, Series A |
| Avoro Ventures | Series C, Series B |
| Avoro Capital | Series B |
Recent news
Latest coverage and updates
- is_developingSep 24, 2026
Hemab is developing franchise of innovative therapeutics.
- hiresSep 24, 2026
Hemab hired Keli as Board of Directors on Sep 24th '26.
- hiresSep 24, 2026
Hemab hired Keli Walbert as Board of Directors on Sep 24th '26.
- launchesJul 12, 2026
Hemab ApS launched HMB-003 program at International Society on Thrombosis and Haemostasis, ISTH, 2026 Congress on Jul 12th '26.
- attends_eventJul 12, 2026
Hemab ApS attended event International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress on Jul 12th '26.
Hemab Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access